| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.858 | 0.004 | 0.858 | Spasmolytic | 0.686 0.007 DBMET01652 0.193 0.125 DBMET01651 | ||
| 0.832 | 0.003 | 0.832 | Antihistaminic | 0.474 0.005 DBMET01652 | ||
| 0.817 | 0.003 | 0.817 | Histamine antagonist | 0.464 0.005 DBMET01652 | ||
| 0.811 | 0.003 | 0.811 | Histamine H1 receptor antagonist | 0.325 0.005 DBMET01652 | ||
| 0.667 | 0.005 | 0.667 | Histamine release inhibitor | 0.523 0.022 DBMET01652 0.427 0.062 DBMET01651 | ||
| 0.62 | 0.004 | 0.877 | 5 Hydroxytryptamine uptake inhibitor | 0.877 0.002 DBMET01652 | DBMET01652 | |
| 0.608 | 0.015 | 0.608 | Vasodilator, peripheral | 0.445 0.042 DBMET01652 0.29 0.102 DBMET01651 | ||
| 0.573 | 0.004 | 0.589 | Cholinergic antagonist | 0.589 0.004 DBMET01652 | DBMET01652 | |
| 0.565 | 0.004 | 0.585 | Acetylcholine antagonist | 0.585 0.004 DBMET01652 | DBMET01652 | |
| 0.546 | 0.009 | 0.546 | Anticonvulsant | 0.367 0.026 DBMET01652 | ||
| 0.524 | 0.004 | 0.524 | Acetylcholine muscarinic antagonist | 0.485 0.004 DBMET01652 | ||
| 0.505 | 0.002 | 0.804 | Dopamine transporter inhibitor | 0.804 0.001 DBMET01652 | DBMET01652 | |
| 0.503 | 0.005 | 0.503 | 5 Hydroxytryptamine 2B antagonist | 0.194 0.028 DBMET01652 | ||
| 0.498 | 0.004 | 0.501 | Acetylcholine M1 receptor antagonist | 0.501 0.004 DBMET01652 | DBMET01652 | |
| 0.496 | 0.004 | 0.496 | Alpha 2b adrenoreceptor antagonist | 0.281 0.011 DBMET01652 | ||
| 0.447 | 0.004 | 0.447 | Dopamine D4 agonist | 0.413 0.004 DBMET01652 | ||
| 0.422 | 0.004 | 0.508 | Dopamine uptake inhibitor | 0.508 0.003 DBMET01652 | DBMET01652 | |
| 0.455 | 0.048 | 0.724 | Antiobesity | 0.724 0.009 DBMET01652 | DBMET01652 | |
| 0.412 | 0.009 | 0.412 | 5 Hydroxytryptamine 2 antagonist | 0.212 0.028 DBMET01652 | ||
| 0.419 | 0.019 | 0.42 | Potassium channel blocker | 0.42 0.019 DBMET01652 | DBMET01652 | |
| 0.399 | 0.008 | 0.399 | Dopamine antagonist | 0.105 0.036 DBMET01652 | ||
| 0.428 | 0.05 | 0.621 | Toll-Like receptor 7 agonist | 0.621 0.015 DBMET01652 | DBMET01652 | |
| 0.385 | 0.007 | 0.385 | Anesthetic local | 0.183 0.037 DBMET01652 0.148 0.05 DBMET01651 | ||
| 0.402 | 0.026 | 0.549 | Potassium channel (Voltage-sensitive) blocker | 0.549 0.01 DBMET01652 | DBMET01652 | |
| 0.422 | 0.052 | 0.614 | Toll-Like receptor agonist | 0.614 0.015 DBMET01652 | DBMET01652 | |
| 0.378 | 0.018 | 0.378 | P-glycoprotein inhibitor | 0.164 0.096 DBMET01652 0.169 0.091 DBMET01651 | ||
| 0.368 | 0.008 | 0.368 | 5 Hydroxytryptamine 2A antagonist | 0.19 0.021 DBMET01652 | ||
| 0.36 | 0.005 | 0.36 | Alpha 2c adrenoreceptor antagonist | 0.207 0.017 DBMET01652 | ||
| 0.359 | 0.009 | 0.359 | Nav1.2 sodium channel blocker | 0.165 0.049 DBMET01652 0.162 0.05 DBMET01651 | ||
| 0.38 | 0.031 | 0.565 | HERG channel blocker | 0.565 0.01 DBMET01652 | DBMET01652 | |
| 0.354 | 0.006 | 0.354 | Nav1.3 sodium channel blocker | 0.175 0.034 DBMET01652 0.137 0.057 DBMET01651 | ||
| 0.355 | 0.008 | 0.355 | Dopamine D2 antagonist | 0.076 0.041 DBMET01652 | ||
| 0.35 | 0.004 | 0.703 | Adrenaline uptake inhibitor | 0.703 0.002 DBMET01652 | DBMET01652 | |
| 0.39 | 0.052 | 0.425 | Cholesterol antagonist | 0.285 0.101 DBMET01652 0.425 0.045 DBMET01651 | DBMET01651 | |
| 0.34 | 0.004 | 0.341 | Acetylcholine M2 receptor antagonist | 0.341 0.004 DBMET01652 | DBMET01652 | |
| 0.341 | 0.005 | 0.341 | Dopamine D3 antagonist | 0.09 0.028 DBMET01652 | ||
| 0.353 | 0.036 | 0.728 | Superoxide dismutase inhibitor | 0.256 0.071 DBMET01652 0.728 0.004 DBMET01651 | DBMET01651 | |
| 0.313 | 0.004 | 0.313 | Histamine H3 receptor antagonist | 0.11 0.01 DBMET01652 | ||
| 0.312 | 0.008 | 0.312 | Nav1.1 sodium channel blocker | 0.136 0.039 DBMET01652 0.184 0.022 DBMET01651 | ||
| 0.318 | 0.017 | 0.318 | 5 Hydroxytryptamine antagonist | 0.215 0.031 DBMET01652 | ||
| 0.308 | 0.009 | 0.308 | 5 Hydroxytryptamine 2C antagonist | 0.164 0.023 DBMET01652 | ||
| 0.302 | 0.005 | 0.302 | Sigma receptor antagonist | 0.05 0.035 DBMET01652 | ||
| 0.3 | 0.007 | 0.3 | Dopamine D4 antagonist | 0.115 0.022 DBMET01652 | ||
| 0.323 | 0.06 | 0.412 | Lipoxygenase inhibitor | 0.178 0.165 DBMET01652 0.412 0.034 DBMET01651 | DBMET01651 | |
| 0.264 | 0.009 | 0.264 | Mediator release inhibitor | 0.169 0.022 DBMET01652 | ||
| 0.251 | 0.007 | 0.251 | Dopamine agonist | 0.231 0.008 DBMET01652 | ||
| 0.294 | 0.05 | 0.294 | Hypolipemic | 0.191 0.101 DBMET01652 | ||
| 0.271 | 0.028 | 0.282 | Neurotrophic factor enhancer | 0.146 0.144 DBMET01652 0.282 0.023 DBMET01651 | DBMET01651 | |
| 0.316 | 0.075 | 0.316 | Vasodilator, coronary | 0.304 0.084 DBMET01652 0.237 0.147 DBMET01651 | ||
| 0.297 | 0.057 | 0.297 | Cardiotonic | 0.23 0.096 DBMET01652 | ||
| 0.244 | 0.005 | 0.287 | Acetylcholine M3 receptor antagonist | 0.287 0.004 DBMET01652 | DBMET01652 | |
| 0.257 | 0.025 | 0.257 | Lipid peroxidase inhibitor | 0.179 0.051 DBMET01652 0.141 0.075 DBMET01651 | ||
| 0.252 | 0.028 | 0.252 | Cholinergic | 0.217 0.039 DBMET01652 0.136 0.089 DBMET01651 | ||
| 0.224 | 0.006 | 0.224 | Sphingomyelinase inhibitor | 0.205 0.009 DBMET01652 0.084 0.08 DBMET01651 | ||
| 0.228 | 0.011 | 0.228 | Alpha 2a adrenoreceptor antagonist | 0.221 0.011 DBMET01652 | ||
| 0.234 | 0.024 | 0.234 | Acetylcholinesterase inhibitor | 0.113 0.085 DBMET01652 0.175 0.042 DBMET01651 | ||
| 0.21 | 0.005 | 0.264 | Acetylcholine M4 receptor antagonist | 0.264 0.004 DBMET01652 | DBMET01652 | |
| 0.255 | 0.056 | 0.255 | Amyloid beta aggregation inhibitor | 0.218 0.069 DBMET01652 | ||
| 0.221 | 0.024 | 0.221 | Alpha adrenoreceptor antagonist | 0.132 0.043 DBMET01652 | ||
| 0.198 | 0.005 | 0.198 | Histamine H2 receptor antagonist | 0.128 0.017 DBMET01652 | ||
| 0.203 | 0.01 | 0.203 | Dopamine D1 antagonist | 0.084 0.031 DBMET01652 | ||
| 0.216 | 0.024 | 0.216 | Calcium channel blocker | |||
| 0.286 | 0.098 | 0.341 | Antithrombotic | 0.341 0.068 DBMET01652 0.252 0.125 DBMET01651 | DBMET01652 | |
| 0.204 | 0.018 | 0.204 | Nav1.6 sodium channel blocker | 0.149 0.055 DBMET01652 0.12 0.096 DBMET01651 | ||
| 0.19 | 0.005 | 0.209 | Acetylcholine M5 receptor antagonist | 0.209 0.005 DBMET01652 | DBMET01652 | |
| 0.196 | 0.018 | 0.214 | Alpha 2 adrenoreceptor antagonist | 0.214 0.015 DBMET01652 | DBMET01652 | |
| 0.212 | 0.041 | 0.24 | Antipruritic | 0.24 0.028 DBMET01652 | DBMET01652 | |
| 0.187 | 0.018 | 0.187 | Alpha 1a adrenoreceptor antagonist | 0.1 0.036 DBMET01652 | ||
| 0.189 | 0.022 | 0.189 | Alpha 1 adrenoreceptor antagonist | 0.098 0.044 DBMET01652 | ||
| 0.177 | 0.012 | 0.177 | Alpha 1d adrenoreceptor antagonist | 0.054 0.045 DBMET01652 | ||
| 0.302 | 0.14 | 0.302 | Analgesic | |||
| 0.161 | 0.005 | 0.161 | Oleamide hydrolase inhibitor | 0.07 0.016 DBMET01652 0.13 0.005 DBMET01651 | ||
| 0.175 | 0.021 | 0.175 | Vanilloid 1 agonist | 0.155 0.034 DBMET01652 0.154 0.034 DBMET01651 | ||
| 0.171 | 0.018 | 0.171 | Alpha 1b adrenoreceptor antagonist | 0.074 0.05 DBMET01652 | ||
| 0.17 | 0.02 | 0.17 | 5 Hydroxytryptamine 1 antagonist | 0.069 0.054 DBMET01652 | ||
| 0.18 | 0.03 | 0.18 | Adenylate cyclase inhibitor | 0.131 0.059 DBMET01652 0.145 0.048 DBMET01651 | ||
| 0.151 | 0.009 | 0.16 | Leukotriene synthesis inhibitor | 0.137 0.012 DBMET01652 0.16 0.008 DBMET01651 | DBMET01651 | |
| 0.158 | 0.017 | 0.158 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.246 | 0.107 | 0.246 | Ca(v)3.3 blocker | |||
| 0.134 | 0.005 | 0.165 | Histamine agonist | 0.165 0.004 DBMET01652 | DBMET01652 | |
| 0.147 | 0.021 | 0.147 | 5 Hydroxytryptamine 1A antagonist | 0.07 0.046 DBMET01652 | ||
| 0.136 | 0.012 | 0.136 | Calcium channel L-type blocker | |||
| 0.125 | 0.005 | 0.125 | Sigma 1 receptor antagonist | |||
| 0.208 | 0.088 | 0.296 | Cyclic AMP phosphodiesterase inhibitor | 0.296 0.043 DBMET01652 | DBMET01652 | |
| 0.153 | 0.037 | 0.225 | 5-Lipoxygenase inhibitor | 0.225 0.02 DBMET01651 | DBMET01651 | |
| 0.152 | 0.035 | 0.152 | Antiadrenergic | 0.1 0.056 DBMET01652 | ||
| 0.155 | 0.042 | 0.267 | Cholesterol synthesis inhibitor | 0.267 0.015 DBMET01651 | DBMET01651 | |
| 0.256 | 0.143 | 0.341 | Immunosuppressant | 0.341 0.092 DBMET01651 | DBMET01651 | |
| 0.145 | 0.036 | 0.145 | Adrenaline antagonist | 0.097 0.055 DBMET01652 | ||
| 0.145 | 0.036 | 0.145 | Calcium channel (voltage-sensitive) blocker | |||
| 0.171 | 0.064 | 0.203 | Arachidonic acid antagonist | 0.185 0.048 DBMET01652 0.203 0.03 DBMET01651 | DBMET01651 | |
| 0.191 | 0.085 | 0.318 | Psychostimulant | 0.318 0.038 DBMET01652 | DBMET01652 | |
| 0.124 | 0.027 | 0.124 | Histamine N-methyltransferase inhibitor | 0.124 0.027 DBMET01652 | ||
| 0.101 | 0.005 | 0.101 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 DBMET01652 0.018 0.015 DBMET01651 | ||
| 0.11 | 0.024 | 0.11 | Vanilloid agonist | 0.108 0.026 DBMET01651 | ||
| 0.16 | 0.075 | 0.229 | Thrombolytic | 0.229 0.04 DBMET01652 | DBMET01652 | |
| 0.115 | 0.036 | 0.232 | Glutamate (mGluR7) agonist | 0.232 0.004 DBMET01652 | DBMET01652 | |
| 0.123 | 0.043 | 0.156 | Electron transport complex I inhibitor | 0.156 0.018 DBMET01651 | DBMET01651 | |
| 0.089 | 0.011 | 0.089 | 5-Alpha-reductase inhibitor | 0.034 0.029 DBMET01652 0.034 0.029 DBMET01651 | ||
| 0.104 | 0.026 | 0.104 | Interferon agonist | 0.088 0.041 DBMET01652 0.083 0.048 DBMET01651 | ||
| 0.099 | 0.026 | 0.099 | Epoxide hydrolase inhibitor | 0.095 0.029 DBMET01652 | ||
| 0.141 | 0.069 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 DBMET01652 0.15 0.042 DBMET01651 | DBMET01652 | |
| 0.096 | 0.027 | 0.096 | Amidase inhibitor | 0.087 0.032 DBMET01651 | ||
| 0.103 | 0.037 | 0.16 | Acetylcholine nicotinic antagonist | 0.16 0.018 DBMET01652 | DBMET01652 | |
| 0.291 | 0.225 | 0.418 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.418 0.085 DBMET01652 0.393 0.107 DBMET01651 | DBMET01652 | |
| 0.174 | 0.119 | 0.204 | Antiamyloidogenic | 0.204 0.097 DBMET01652 | DBMET01652 | |
| 0.059 | 0.004 | 0.059 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET01652 | ||
| 0.069 | 0.018 | 0.089 | Nicotinic alpha3beta2 receptor antagonist | 0.089 0.01 DBMET01652 0.049 0.047 DBMET01651 | DBMET01652 | |
| 0.066 | 0.016 | 0.066 | Squalene epoxidase inhibitor | 0.06 0.021 DBMET01651 | ||
| 0.057 | 0.008 | 0.057 | Delayed rectifier potassium channel blocker | 0.039 0.022 DBMET01651 | ||
| 0.076 | 0.031 | 0.254 | CDC25B inhibitor | 0.254 0.004 DBMET01651 | DBMET01651 | |
| 0.098 | 0.053 | 0.11 | Bile acid receptor antagonist | 0.11 0.031 DBMET01651 | DBMET01651 | |
| 0.061 | 0.017 | 0.061 | Cholesterol esterase inhibitor | 0.045 0.038 DBMET01651 | ||
| 0.085 | 0.042 | 0.085 | Estrogen receptor alpha antagonist | |||
| 0.064 | 0.022 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.014 DBMET01651 | DBMET01651 | |
| 0.128 | 0.086 | 0.138 | Farnesoid X receptor antagonist | 0.138 0.069 DBMET01651 | DBMET01651 | |
| 0.113 | 0.072 | 0.113 | Calcium channel N-type blocker | |||
| 0.053 | 0.014 | 0.056 | GABA uptake inhibitor | 0.056 0.012 DBMET01652 0.039 0.028 DBMET01651 | DBMET01652 | |
| 0.049 | 0.01 | 0.049 | Sigma 2 receptor antagonist | |||
| 0.075 | 0.037 | 0.079 | 5 Hydroxytryptamine 1B antagonist | 0.079 0.035 DBMET01652 | DBMET01652 | |
| 0.133 | 0.096 | 0.264 | Phospholipase A2 inhibitor | 0.264 0.02 DBMET01651 | DBMET01651 | |
| 0.06 | 0.024 | 0.06 | 5 Hydroxytryptamine 4 antagonist | 0.048 0.043 DBMET01652 | ||
| 0.21 | 0.175 | 0.21 | Sodium/bile acid cotransporter inhibitor | |||
| 0.132 | 0.1 | 0.132 | Sigma receptor agonist | |||
| 0.071 | 0.039 | 0.071 | Leukotriene antagonist | |||
| 0.134 | 0.104 | 0.155 | Interferon gamma antagonist | 0.142 0.089 DBMET01652 0.155 0.072 DBMET01651 | DBMET01651 | |
| 0.162 | 0.132 | 0.162 | Platelet antagonist | 0.161 0.133 DBMET01652 | ||
| 0.053 | 0.023 | 0.053 | Dopamine D5 antagonist | |||
| 0.083 | 0.054 | 0.083 | CC chemokine 5 receptor agonist | |||
| 0.121 | 0.093 | 0.142 | Neurotrophic factor | 0.142 0.066 DBMET01651 | DBMET01651 | |
| 0.142 | 0.117 | 0.175 | Lipocortins synthesis antagonist | 0.175 0.076 DBMET01652 | DBMET01652 | |
| 0.07 | 0.044 | 0.093 | Acetylcholine M5 receptor agonist | 0.093 0.024 DBMET01652 | DBMET01652 | |
| 0.188 | 0.163 | 0.266 | MAP kinase kinase 3 inhibitor | 0.266 0.02 DBMET01652 | DBMET01652 | |
| 0.157 | 0.133 | 0.382 | Aldehyde oxidase inhibitor | 0.182 0.115 DBMET01652 0.382 0.05 DBMET01651 | DBMET01651 | |
| 0.074 | 0.05 | 0.138 | CDC25A inhibitor | 0.138 0.015 DBMET01651 | DBMET01651 | |
| 0.192 | 0.168 | 0.451 | 5 Hydroxytryptamine uptake stimulant | 0.451 0.007 DBMET01652 0.31 0.04 DBMET01651 | DBMET01652 | |
| 0.094 | 0.07 | 0.157 | Bronchodilator | 0.157 0.029 DBMET01652 | DBMET01652 | |
| 0.128 | 0.106 | 0.181 | Adenylate cyclase stimulant | 0.181 0.025 DBMET01652 0.143 0.076 DBMET01651 | DBMET01652 | |
| 0.143 | 0.121 | 0.212 | Anesthetic general | 0.212 0.068 DBMET01651 | DBMET01651 | |
| 0.064 | 0.043 | 0.064 | Calcium channel P-type blocker | 0.063 0.045 DBMET01652 | ||
| 0.072 | 0.051 | 0.103 | Glycine receptor agonist | 0.103 0.019 DBMET01652 0.094 0.025 DBMET01651 | DBMET01652 | |
| 0.185 | 0.164 | 0.311 | Tyrosine 3 hydroxylase inhibitor | 0.311 0.028 DBMET01652 0.248 0.07 DBMET01651 | DBMET01652 | |
| 0.049 | 0.029 | 0.049 | 5 Hydroxytryptamine 1A agonist | |||
| 0.063 | 0.047 | 0.108 | Beta 3 adrenoreceptor antagonist | 0.108 0.013 DBMET01652 | DBMET01652 | |
| 0.061 | 0.045 | 0.072 | Beta 2 adrenoreceptor agonist | 0.072 0.016 DBMET01652 | DBMET01652 | |
| 0.068 | 0.053 | 0.068 | Cannabinoid receptor antagonist | |||
| 0.038 | 0.024 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.079 | 0.065 | 0.098 | Calcium antagonist | 0.098 0.049 DBMET01652 | DBMET01652 | |
| 0.088 | 0.075 | 0.088 | Alpha 2d adrenoreceptor antagonist | |||
| 0.117 | 0.105 | 0.149 | Sphingosine 1-phosphate receptor 2 antagonist | 0.149 0.042 DBMET01651 | DBMET01651 | |
| 0.035 | 0.024 | 0.035 | Glutamate (mGluR group II) agonist | |||
| 0.051 | 0.041 | 0.074 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET01652 0.069 0.017 DBMET01651 | DBMET01652 | |
| 0.084 | 0.074 | 0.227 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.1 0.054 DBMET01652 0.227 0.012 DBMET01651 | DBMET01651 | |
| 0.157 | 0.147 | 0.157 | Vasodilator | |||
| 0.05 | 0.041 | 0.076 | Vanilloid 2 antagonist | 0.076 0.011 DBMET01651 | DBMET01651 | |
| 0.024 | 0.015 | 0.024 | Prostaglandin EP2 agonist | 0.023 0.016 DBMET01651 | ||
| 0.05 | 0.041 | 0.05 | Alpha 1L adrenoreceptor antagonist | 0.049 0.046 DBMET01652 | ||
| 0.044 | 0.036 | 0.044 | Potassium channel Kv1.3 blocker | |||
| 0.031 | 0.025 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 DBMET01652 0.03 0.028 DBMET01651 | DBMET01652 | |
| 0.025 | 0.021 | 0.032 | Histamine H3 receptor agonist | 0.032 0.016 DBMET01652 | DBMET01652 | |
| 0.048 | 0.045 | 0.051 | Acetyl-CoA transferase inhibitor | 0.051 0.039 DBMET01651 | DBMET01651 | |
| 0.053 | 0.05 | 0.053 | Calcium channel T-type blocker | |||
| 0.049 | 0.05 | 0.089 | Glucosylceramidase inhibitor | 0.089 0.011 DBMET01652 | DBMET01652 | |
| 0.05 | 0.053 | 0.064 | 5 Hydroxytryptamine 7 agonist | 0.064 0.026 DBMET01652 | DBMET01652 | |
| 0.168 | 0.171 | 0.277 | DNA synthesis inhibitor | 0.238 0.075 DBMET01652 0.277 0.052 DBMET01651 | DBMET01651 | |
| 0.034 | 0.04 | 0.097 | Acetylcholine M1 receptor agonist | 0.097 0.013 DBMET01652 | DBMET01652 | |
| 0.072 | 0.077 | 0.153 | Ornithine decarboxylase inhibitor | 0.078 0.07 DBMET01652 0.153 0.01 DBMET01651 | DBMET01651 | |
| 0.175 | 0.186 | 0.207 | Gastrin inhibitor | 0.207 0.138 DBMET01651 | DBMET01651 | |
| 0.081 | 0.095 | 0.117 | Anabolic | 0.104 0.057 DBMET01652 0.117 0.043 DBMET01651 | DBMET01651 | |
| 0.042 | 0.056 | 0.111 | Acetylcholine muscarinic agonist | 0.111 0.015 DBMET01652 | DBMET01652 | |
| 0.251 | 0.266 | 0.431 | Antiinflammatory | 0.431 0.121 DBMET01651 | DBMET01651 | |
| 0.12 | 0.136 | 0.317 | Melanin inhibitor | 0.317 0.02 DBMET01651 | DBMET01651 | |
| 0.065 | 0.082 | 0.137 | Adrenaline agonist | 0.137 0.019 DBMET01652 | DBMET01652 | |
| 0.064 | 0.081 | 0.164 | Acetylcholine M3 receptor agonist | 0.164 0.013 DBMET01652 | DBMET01652 | |
| 0.027 | 0.046 | 0.049 | Retinoid X alpha receptor antagonist | 0.049 0.007 DBMET01651 | DBMET01651 | |
| 0.074 | 0.093 | 0.114 | Estrogen-related receptor beta agonist | 0.114 0.013 DBMET01651 | DBMET01651 | |
| 0.059 | 0.08 | 0.113 | Nicotinic alpha4beta2 receptor antagonist | 0.113 0.022 DBMET01652 0.067 0.066 DBMET01651 | DBMET01652 | |
| 0.029 | 0.052 | 0.056 | Retinoid X receptor antagonist | 0.056 0.008 DBMET01651 | DBMET01651 | |
| 0.032 | 0.055 | 0.051 | Sphingosine kinase 1 inhibitor | 0.051 0.015 DBMET01652 | DBMET01652 | |
| 0.033 | 0.057 | 0.071 | Mannosidase inhibitor | 0.071 0.011 DBMET01652 0.052 0.023 DBMET01651 | DBMET01652 | |
| 0.047 | 0.072 | 0.075 | Sphingosine kinase inhibitor | 0.075 0.019 DBMET01652 | DBMET01652 | |
| 0.021 | 0.047 | 0.031 | Glutamate (mGluR2) antagonist | 0.031 0.019 DBMET01652 | DBMET01652 | |
| 0.135 | 0.163 | 0.2 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.2 0.073 DBMET01652 | DBMET01652 | |
| 0.131 | 0.158 | 0.191 | Platelet aggregation inhibitor | 0.191 0.088 DBMET01652 | DBMET01652 | |
| 0.026 | 0.054 | 0.044 | Glutamate (mGluR group II) antagonist | 0.044 0.02 DBMET01652 | DBMET01652 | |
| 0.007 | 0.037 | 0.017 | 3C-Like protease (MERS coronavirus) inhibitor | 0.012 0.008 DBMET01652 0.017 0.004 DBMET01651 | DBMET01651 | |
| 0.03 | 0.063 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.035 DBMET01652 | DBMET01652 | |
| 0.01 | 0.044 | 0.028 | Epoxide hydrolase 2 inhibitor | 0.028 0.015 DBMET01652 | DBMET01652 | |
| 0.192 | 0.227 | 0.36 | Calcium channel activator | 0.36 0.043 DBMET01652 | DBMET01652 | |
| 0.036 | 0.072 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.025 DBMET01651 | DBMET01651 | |
| 0.036 | 0.072 | 0.086 | Histamine H4 receptor antagonist | 0.086 0.007 DBMET01652 | DBMET01652 | |
| 0.057 | 0.094 | 0.063 | MDM2 inhibitor | 0.063 0.062 DBMET01651 | DBMET01651 | |
| 0.087 | 0.124 | 0.371 | Alpha-N-acetylglucosaminidase inhibitor | 0.371 0.01 DBMET01652 0.336 0.013 DBMET01651 | DBMET01652 | |
| 0.167 | 0.206 | 0.305 | Transcription factor NF kappa B inhibitor | 0.305 0.091 DBMET01651 | DBMET01651 | |
| 0.013 | 0.052 | 0.025 | 5 Hydroxytryptamine 1D agonist | 0.025 0.024 DBMET01652 | DBMET01652 | |
| 0.027 | 0.068 | 0.067 | Acid-sensing ion channel blocker | 0.067 0.007 DBMET01652 | DBMET01652 | |
| 0.014 | 0.055 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 DBMET01652 | DBMET01652 | |
| 0.146 | 0.187 | 0.184 | Hypoglycemic | 0.184 0.129 DBMET01651 | DBMET01651 | |
| 0.011 | 0.052 | 0.028 | Retinoid X beta receptor agonist | 0.028 0.009 DBMET01651 | DBMET01651 | |
| 0.039 | 0.081 | 0.067 | Sphingosine kinase 2 inhibitor | 0.067 0.024 DBMET01652 | DBMET01652 | |
| 0.111 | 0.153 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | 0.149 0.064 DBMET01651 | DBMET01651 | |
| 0.111 | 0.154 | 0.168 | Nitric oxide antagonist | 0.168 0.083 DBMET01651 | DBMET01651 | |
| 0.02 | 0.063 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 DBMET01652 | DBMET01652 | |
| 0.018 | 0.065 | 0.029 | Cholesterol ester transfer protein antagonist | 0.029 0.026 DBMET01652 | DBMET01652 | |
| 0.123 | 0.172 | 0.365 | Succinate dehydrogenase inhibitor | 0.146 0.12 DBMET01652 0.365 0.005 DBMET01651 | DBMET01651 | |
| 0.01 | 0.063 | 0.025 | Geranylgeranyltransferase I inhibitor | 0.025 0.011 DBMET01652 | DBMET01652 | |
| 0.068 | 0.121 | 0.29 | Ferrochelatase inhibitor | 0.118 0.055 DBMET01652 0.29 0.009 DBMET01651 | DBMET01651 | |
| 0.041 | 0.094 | 0.088 | Neuronal nicotinic receptor antagonist | 0.088 0.03 DBMET01652 | DBMET01652 | |
| 0.047 | 0.101 | 0.075 | Interferon inducer | 0.075 0.028 DBMET01652 | DBMET01652 | |
| 0.05 | 0.105 | 0.083 | Phospholipase D inhibitor | 0.083 0.03 DBMET01652 | DBMET01652 | |
| 0.01 | 0.066 | 0.026 | Retinoid X gamma receptor agonist | 0.026 0.013 DBMET01651 | DBMET01651 | |
| 0.044 | 0.099 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.115 0.019 DBMET01652 0.078 0.052 DBMET01651 | DBMET01652 | |
| 0.219 | 0.275 | 0.343 | 5 Hydroxytryptamine release inhibitor | 0.287 0.18 DBMET01652 0.343 0.121 DBMET01651 | DBMET01651 | |
| 0.033 | 0.094 | 0.119 | 5 Hydroxytryptamine 6 antagonist | 0.119 0.01 DBMET01652 | DBMET01652 | |
| 0.016 | 0.079 | 0.03 | Retinoid X gamma receptor antagonist | 0.03 0.013 DBMET01651 | DBMET01651 | |
| 0.129 | 0.193 | 0.257 | Antioxidant | 0.257 0.08 DBMET01651 | DBMET01651 | |
| 0.034 | 0.1 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.02 DBMET01652 | DBMET01652 | |
| 0.054 | 0.122 | 0.139 | Acetylcholine agonist | 0.139 0.029 DBMET01652 | DBMET01652 | |
| 0.033 | 0.102 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | 0.053 0.037 DBMET01652 | DBMET01652 | |
| 0.029 | 0.1 | 0.049 | H+/K+-transporting ATPase inhibitor | 0.049 0.039 DBMET01651 | DBMET01651 | |
| 0.039 | 0.116 | 0.103 | Beta adrenoreceptor antagonist | 0.103 0.015 DBMET01652 | DBMET01652 | |
| 0.15 | 0.228 | 0.223 | Neuropeptide Y2 antagonist | 0.223 0.085 DBMET01651 | DBMET01651 | |
| 0.043 | 0.121 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 DBMET01651 | DBMET01651 | |
| 0.04 | 0.121 | 0.074 | Pregnane X receptor antagonist | 0.074 0.01 DBMET01651 | DBMET01651 | |
| 0.028 | 0.11 | 0.06 | 5 Hydroxytryptamine 3 antagonist | 0.06 0.035 DBMET01652 | DBMET01652 | |
| 0.015 | 0.097 | 0.047 | Myristoyl transferase inhibitor | 0.047 0.005 DBMET01652 | DBMET01652 | |
| 0.019 | 0.102 | 0.07 | Glutamate (mGluR3) antagonist | 0.07 0.006 DBMET01652 | DBMET01652 | |
| 0.022 | 0.106 | 0.052 | Leukocyte elastase inhibitor | 0.052 0.023 DBMET01651 | DBMET01651 | |
| 0.055 | 0.141 | 0.109 | Prolactin inhibitor | 0.109 0.046 DBMET01652 | DBMET01652 | |
| 0.161 | 0.248 | 0.287 | Apoptosis antagonist | 0.287 0.094 DBMET01651 | DBMET01651 | |
| 0.029 | 0.116 | 0.106 | 5 Hydroxytryptamine agonist | 0.106 0.032 DBMET01652 | DBMET01652 | |
| 0.007 | 0.095 | 0.017 | Retinoic acid receptor antagonist | 0.017 0.014 DBMET01651 | DBMET01651 | |
| 0.056 | 0.144 | 0.096 | Creatine kinase inhibitor | 0.096 0.064 DBMET01652 | DBMET01652 | |
| 0.058 | 0.147 | 0.238 | UDP-glucose 4-epimerase inhibitor | 0.136 0.034 DBMET01652 0.238 0.014 DBMET01651 | DBMET01651 | |
| 0.043 | 0.133 | 0.067 | Ryanodine receptor antagonist | 0.067 0.022 DBMET01652 | DBMET01652 | |
| 0.024 | 0.116 | 0.089 | NMDA 2C receptor antagonist | 0.089 0.02 DBMET01652 | DBMET01652 | |
| 0.031 | 0.122 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | 0.063 0.033 DBMET01651 | DBMET01651 | |
| 0.101 | 0.201 | 0.133 | Pregnane X receptor agonist | 0.133 0.09 DBMET01651 | DBMET01651 | |
| 0.028 | 0.131 | 0.048 | Dopamine beta hydroxylase inhibitor | 0.048 0.035 DBMET01651 | DBMET01651 | |
| 0.016 | 0.122 | 0.085 | Dopamine D5 agonist | 0.085 0.005 DBMET01652 | DBMET01652 | |
| 0.008 | 0.114 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.015 DBMET01651 | DBMET01651 | |
| 0.052 | 0.16 | 0.082 | GABA B receptor agonist | 0.08 0.041 DBMET01652 0.082 0.037 DBMET01651 | DBMET01651 | |
| 0.126 | 0.234 | 0.597 | 5 Hydroxytryptamine release stimulant | 0.597 0.015 DBMET01652 0.176 0.145 DBMET01651 | DBMET01652 | |
| 0.008 | 0.119 | 0.064 | Progesterone antagonist | 0.064 0.013 DBMET01651 | DBMET01651 | |
| 0.006 | 0.119 | 0.02 | Retinoic acid alpha receptor antagonist | 0.02 0.014 DBMET01651 | DBMET01651 | |
| 0.026 | 0.141 | 0.081 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.081 0.016 DBMET01651 | DBMET01651 | |
| 0.025 | 0.143 | 0.067 | Carbamoyl phosphate synthetase inhibitor | 0.067 0.037 DBMET01652 | DBMET01652 | |
| 0.061 | 0.181 | 0.194 | 3C-Like protease (SARS coronavirus) inhibitor | 0.194 0.005 DBMET01651 | DBMET01651 | |
| 0.035 | 0.156 | 0.055 | Ca(v)3.2 blocker | 0.055 0.051 DBMET01652 | DBMET01652 | |
| 0.022 | 0.143 | 0.039 | Thymidine kinase inhibitor | 0.039 0.031 DBMET01652 | DBMET01652 | |
| 0.01 | 0.132 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.014 DBMET01651 | DBMET01651 | |
| 0.01 | 0.133 | 0.023 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET01651 | DBMET01651 | |
| 0.021 | 0.145 | 0.065 | Acetylcholine M2 receptor agonist | 0.065 0.024 DBMET01652 | DBMET01652 | |
| 0.067 | 0.193 | 0.331 | TRPA1 agonist | 0.331 0.004 DBMET01651 | DBMET01651 | |
| 0.041 | 0.17 | 0.104 | Glycine receptor antagonist | 0.104 0.029 DBMET01652 | DBMET01652 | |
| 0.025 | 0.156 | 0.047 | HCV NS3/NS4A protease inhibitor | 0.047 0.039 DBMET01652 | DBMET01652 | |
| 0.02 | 0.155 | 0.156 | Argininosuccinate synthase inhibitor | 0.051 0.046 DBMET01652 0.156 0.011 DBMET01651 | DBMET01651 | |
| 0.066 | 0.203 | 0.179 | Cathepsin H inhibitor | 0.12 0.075 DBMET01652 0.179 0.029 DBMET01651 | DBMET01651 | |
| 0.072 | 0.209 | 0.121 | Protein kinase stimulant | 0.121 0.092 DBMET01652 0.108 0.107 DBMET01651 | DBMET01652 | |
| 0.022 | 0.16 | 0.074 | Nicotinic receptor alpha4 subunit antagonist | 0.074 0.015 DBMET01652 | DBMET01652 | |
| 0.019 | 0.157 | 0.049 | Acyl-CoA dehydrogenase inhibitor | 0.048 0.045 DBMET01652 0.049 0.043 DBMET01651 | DBMET01651 | |
| 0.023 | 0.164 | 0.039 | Kainate receptor agonist | 0.039 0.036 DBMET01651 | DBMET01651 | |
| 0.103 | 0.246 | 0.14 | CC chemokine 6 receptor antagonist | 0.14 0.04 DBMET01651 | DBMET01651 | |
| 0.011 | 0.154 | 0.032 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET01651 | DBMET01651 | |
| 0.11 | 0.255 | 0.21 | 5 Hydroxytryptamine 1E antagonist | 0.21 0.119 DBMET01652 | DBMET01652 | |
| 0.044 | 0.192 | 0.116 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 DBMET01652 0.116 0.042 DBMET01651 | DBMET01651 | |
| 0.016 | 0.164 | 0.063 | Glutamate (mGluR5) agonist | 0.063 0.016 DBMET01652 | DBMET01652 | |
| 0.008 | 0.157 | 0.03 | Retinoid X receptor agonist | 0.03 0.029 DBMET01651 | DBMET01651 | |
| 0.02 | 0.169 | 0.04 | Potassium channel Kv1.1 blocker | 0.04 0.022 DBMET01651 | DBMET01651 | |
| 0.051 | 0.205 | 0.112 | Lanosterol 14 alpha demethylase inhibitor | 0.112 0.039 DBMET01652 | DBMET01652 | |
| 0.011 | 0.167 | 0.047 | Histone deacetylase class IV inhibitor | 0.047 0.014 DBMET01651 | DBMET01651 | |
| 0.011 | 0.167 | 0.047 | Histone deacetylase 11 inhibitor | 0.047 0.014 DBMET01651 | DBMET01651 | |
| 0.061 | 0.219 | 0.118 | Photosensitizer | 0.118 0.06 DBMET01651 | DBMET01651 | |
| 0.143 | 0.302 | 0.353 | GABA C receptor rho-3 antagonist | 0.353 0.084 DBMET01652 0.309 0.11 DBMET01651 | DBMET01652 | |
| 0.023 | 0.182 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.035 DBMET01652 0.066 0.014 DBMET01651 | DBMET01651 | |
| 0.005 | 0.166 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.026 DBMET01652 | DBMET01652 | |
| 0.008 | 0.17 | 0.035 | Histone deacetylase 4 inhibitor | 0.035 0.02 DBMET01651 | DBMET01651 | |
| 0.019 | 0.185 | 0.043 | Adenylate cyclase 1 inhibitor | 0.043 0.038 DBMET01652 | DBMET01652 | |
| 0.006 | 0.173 | 0.032 | Imidazoline I1 receptor antagonist | 0.032 0.006 DBMET01652 | DBMET01652 | |
| 0.084 | 0.252 | 0.133 | Tumour necrosis factor antagonist | 0.133 0.123 DBMET01651 | DBMET01651 | |
| 0.022 | 0.195 | 0.075 | Androgen agonist | 0.075 0.027 DBMET01652 | DBMET01652 | |
| 0.016 | 0.193 | 0.062 | Histone deacetylase 9 inhibitor | 0.062 0.011 DBMET01651 | DBMET01651 | |
| 0.003 | 0.181 | 0.01 | Imidazoline I2 receptor antagonist | 0.01 0.009 DBMET01652 | DBMET01652 | |
| 0.049 | 0.227 | 0.108 | Proteasome inhibitor | 0.108 0.077 DBMET01651 | DBMET01651 | |
| 0.032 | 0.212 | 0.085 | GABA aminotransferase inhibitor | 0.085 0.04 DBMET01651 | DBMET01651 | |
| 0.027 | 0.21 | 0.067 | Aminopeptidase I inhibitor | 0.067 0.057 DBMET01652 | DBMET01652 | |
| 0.021 | 0.207 | 0.273 | Catalase inhibitor | 0.273 0.007 DBMET01651 | DBMET01651 | |
| 0.011 | 0.199 | 0.064 | Glutamate (mGluR group I) agonist | 0.064 0.02 DBMET01652 | DBMET01652 | |
| 0.132 | 0.32 | 0.211 | 5 Hydroxytryptamine 3E antagonist | 0.211 0.046 DBMET01652 0.168 0.141 DBMET01651 | DBMET01652 | |
| 0.11 | 0.299 | 0.248 | Hypoxia-inducible factor 1 alpha inhibitor | 0.248 0.103 DBMET01651 | DBMET01651 | |
| 0.068 | 0.258 | 0.131 | Sphingosine 1-phosphate receptor 4 antagonist | 0.131 0.055 DBMET01651 | DBMET01651 | |
| 0.05 | 0.241 | 0.082 | Thioredoxin reductase inhibitor | 0.082 0.057 DBMET01651 | DBMET01651 | |
| 0.012 | 0.207 | 0.079 | Histone deacetylase 7 inhibitor | 0.079 0.011 DBMET01651 | DBMET01651 | |
| 0.023 | 0.221 | 0.144 | Glutamate decarboxylase inhibitor | 0.144 0.014 DBMET01651 | DBMET01651 | |
| 0.008 | 0.206 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 DBMET01651 | DBMET01651 | |
| 0.029 | 0.228 | 0.08 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.055 DBMET01652 0.08 0.027 DBMET01651 | DBMET01651 | |
| 0.053 | 0.267 | 0.123 | Cyclooxygenase 3 inhibitor | 0.123 0.074 DBMET01652 | DBMET01652 | |
| 0.041 | 0.256 | 0.151 | Triose-phosphate isomerase inhibitor | 0.098 0.05 DBMET01652 0.151 0.02 DBMET01651 | DBMET01651 | |
| 0.044 | 0.261 | 0.101 | MAP kinase kinase 7 inhibitor | 0.101 0.012 DBMET01652 | DBMET01652 | |
| 0.009 | 0.226 | 0.072 | Ornithine carbamoyltransferase inhibitor | 0.072 0.025 DBMET01651 | DBMET01651 | |
| 0.087 | 0.307 | 0.157 | Phospholipase C inhibitor | 0.157 0.093 DBMET01652 0.141 0.126 DBMET01651 | DBMET01652 | |
| 0.038 | 0.259 | 0.114 | 5 Hydroxytryptamine 3A agonist | 0.114 0.061 DBMET01652 | DBMET01652 | |
| 0.018 | 0.241 | 0.069 | 5 Hydroxytryptamine 3A antagonist | 0.069 0.043 DBMET01652 | DBMET01652 | |
| 0.054 | 0.277 | 0.144 | Adenylate kinase inhibitor | 0.104 0.061 DBMET01652 0.144 0.029 DBMET01651 | DBMET01651 | |
| 0.048 | 0.273 | 0.11 | Microtubule formation inhibitor | 0.11 0.074 DBMET01651 | DBMET01651 | |
| 0.014 | 0.242 | 0.125 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET01652 0.125 0.013 DBMET01651 | DBMET01651 | |
| 0.031 | 0.26 | 0.109 | Falcipain 3 inhibitor | 0.109 0.062 DBMET01651 | DBMET01651 | |
| 0.041 | 0.28 | 0.183 | Caspase 3 inhibitor | 0.183 0.013 DBMET01651 | DBMET01651 | |
| 0.014 | 0.255 | 0.106 | Phosphofructokinase-1 inhibitor | 0.064 0.053 DBMET01652 0.106 0.029 DBMET01651 | DBMET01651 | |
| 0.043 | 0.288 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | 0.079 0.077 DBMET01652 0.105 0.029 DBMET01651 | DBMET01651 | |
| 0.04 | 0.288 | 0.103 | NADH dehydrogenase inhibitor | 0.103 0.04 DBMET01652 | DBMET01652 | |
| 0.013 | 0.262 | 0.045 | Histamine H1 receptor agonist | 0.045 0.028 DBMET01652 | DBMET01652 | |
| 0.012 | 0.261 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.038 DBMET01651 | DBMET01651 | |
| 0.014 | 0.264 | 0.062 | Biliverdin reductase inhibitor | 0.062 0.039 DBMET01652 | DBMET01652 | |
| 0.014 | 0.265 | 0.064 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.043 DBMET01651 | DBMET01651 | |
| 0.018 | 0.27 | 0.074 | Lipase inhibitor | 0.074 0.05 DBMET01651 | DBMET01651 | |
| 0.017 | 0.269 | 0.049 | Aconitate hydratase inhibitor | 0.049 0.041 DBMET01651 | DBMET01651 | |
| 0.039 | 0.294 | 0.325 | Amylase inhibitor | 0.325 0.015 DBMET01651 | DBMET01651 | |
| 0.005 | 0.26 | 0.039 | Histone deacetylase 10 inhibitor | 0.039 0.016 DBMET01651 | DBMET01651 | |
| 0.047 | 0.304 | 0.137 | Toll-Like receptor 2 antagonist | 0.137 0.062 DBMET01652 | DBMET01652 | |
| 0.028 | 0.289 | 0.065 | Glutamate dehydrogenase inhibitor | 0.065 0.064 DBMET01652 | DBMET01652 | |
| 0.032 | 0.293 | 0.11 | Cystathionine beta-synthase inhibitor | 0.11 0.066 DBMET01651 | DBMET01651 | |
| 0.034 | 0.295 | 0.198 | GABA C receptor antagonist | 0.198 0.013 DBMET01652 0.1 0.078 DBMET01651 | DBMET01652 | |
| 0.042 | 0.304 | 0.152 | Interleukin 1b antagonist | 0.152 0.038 DBMET01651 | DBMET01651 | |
| 0.067 | 0.331 | 0.236 | Non-steroidal antiinflammatory agent | 0.236 0.049 DBMET01651 | DBMET01651 | |
| 0.014 | 0.284 | 0.078 | 5 Hydroxytryptamine 2A agonist | 0.078 0.029 DBMET01652 | DBMET01652 | |
| 0.015 | 0.286 | 0.06 | Phenylethanolamine N methyltransferase inhibitor | 0.06 0.008 DBMET01652 | DBMET01652 | |
| 0.07 | 0.342 | 0.137 | CF transmembrane conductance regulator agonist | 0.137 0.103 DBMET01652 | DBMET01652 | |
| 0.023 | 0.296 | 0.047 | Sodium/calcium exchanger inhibitor | 0.047 0.041 DBMET01652 | DBMET01652 | |
| 0.003 | 0.278 | 0.022 | Alpha 2a adrenoreceptor agonist | 0.022 0.008 DBMET01652 | DBMET01652 | |
| 0.146 | 0.425 | 0.289 | Caspase 9 stimulant | 0.289 0.206 DBMET01652 | DBMET01652 | |
| 0.051 | 0.332 | 0.245 | Mannose-6-phosphate isomerase inhibitor | 0.245 0.013 DBMET01651 | DBMET01651 | |
| 0.056 | 0.339 | 0.237 | Interleukin agonist | 0.237 0.089 DBMET01652 | DBMET01652 | |
| 0.008 | 0.292 | 0.04 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 DBMET01652 | DBMET01652 | |
| 0.042 | 0.327 | 0.099 | Nav1.5 sodium channel blocker | 0.099 0.087 DBMET01652 | DBMET01652 | |
| 0.015 | 0.305 | 0.058 | Beta 2 adrenoreceptor antagonist | 0.058 0.025 DBMET01652 | DBMET01652 | |
| 0.042 | 0.338 | 0.112 | DOPA decarboxylase inhibitor | 0.112 0.055 DBMET01651 | DBMET01651 | |
| 0.003 | 0.3 | 0.024 | Alpha 2c adrenoreceptor agonist | 0.024 0.007 DBMET01652 | DBMET01652 | |
| 0.031 | 0.33 | 0.064 | Glutamate (mGluR6) antagonist | 0.064 0.053 DBMET01652 | DBMET01652 | |
| 0.099 | 0.399 | 0.345 | Antibacterial | 0.345 0.105 DBMET01651 | DBMET01651 | |
| 0.029 | 0.331 | 0.315 | GABA C receptor agonist | 0.315 0.009 DBMET01652 0.108 0.059 DBMET01651 | DBMET01652 | |
| 0.011 | 0.314 | 0.049 | Nicotinic neuronal receptor agonist | 0.049 0.047 DBMET01652 | DBMET01652 | |
| 0.014 | 0.319 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.041 DBMET01652 0.057 0.038 DBMET01651 | DBMET01651 | |
| 0.004 | 0.322 | 0.079 | Calpain 1 inhibitor | 0.079 0.004 DBMET01651 | DBMET01651 | |
| 0.039 | 0.359 | 0.159 | Anticoagulant | 0.159 0.073 DBMET01652 | DBMET01652 | |
| 0.016 | 0.339 | 0.074 | CYP2A6 inhibitor | 0.074 0.054 DBMET01652 | DBMET01652 | |
| 0.055 | 0.378 | 0.176 | GABA C receptor rho-2 antagonist | 0.176 0.046 DBMET01652 | DBMET01652 | |
| 0.031 | 0.356 | 0.18 | GABA C receptor rho-1 antagonist | 0.18 0.012 DBMET01652 | DBMET01652 | |
| 0.021 | 0.346 | 0.057 | Dihydroorotate oxidase inhibitor | 0.057 0.034 DBMET01651 | DBMET01651 | |
| 0.015 | 0.342 | 0.081 | Acetylcholine nicotinic agonist | 0.081 0.055 DBMET01652 | DBMET01652 | |
| 0.028 | 0.365 | 0.09 | AMP-activated protein kinase stimulant | 0.09 0.086 DBMET01652 | DBMET01652 | |
| 0.005 | 0.345 | 0.07 | 5 Hydroxytryptamine 2 agonist | 0.07 0.019 DBMET01652 | DBMET01652 | |
| 0.003 | 0.347 | 0.129 | Endothelin B receptor antagonist | 0.129 0.004 DBMET01651 | DBMET01651 | |
| 0.014 | 0.364 | 0.041 | Glutamate (mGluR group III) agonist | 0.041 0.032 DBMET01652 | DBMET01652 | |
| 0.023 | 0.382 | 0.103 | Aminopeptidase B inhibitor | 0.103 0.063 DBMET01651 | DBMET01651 | |
| 0.011 | 0.375 | 0.068 | Vanilloid antagonist | 0.068 0.058 DBMET01651 | DBMET01651 | |
| 0.012 | 0.384 | 0.075 | Porphobilinogen synthase inhibitor | 0.075 0.051 DBMET01651 | DBMET01651 | |
| 0.016 | 0.388 | 0.094 | Protein kinase C zeta inhibitor | 0.094 0.058 DBMET01652 | DBMET01652 | |
| 0.035 | 0.415 | 0.372 | Aldehyde dehydrogenase inhibitor | 0.372 0.006 DBMET01651 | DBMET01651 | |
| 0.008 | 0.396 | 0.175 | TRPA1 antagonist | 0.175 0.007 DBMET01651 | DBMET01651 | |
| 0.041 | 0.429 | 0.293 | Calpain inhibitor | 0.293 0.033 DBMET01651 | DBMET01651 | |
| 0.004 | 0.393 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 DBMET01652 | DBMET01652 | |
| 0.013 | 0.402 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.038 DBMET01652 | DBMET01652 | |
| 0.013 | 0.404 | 0.048 | Potassium channel (Inward rectifier) activator | 0.048 0.039 DBMET01652 | DBMET01652 | |
| 0.023 | 0.417 | 0.17 | Cyclooxygenase 1 inhibitor | 0.17 0.048 DBMET01651 | DBMET01651 | |
| 0.035 | 0.435 | 0.354 | ABCA1 expression enhancer | 0.354 0.004 DBMET01651 | DBMET01651 | |
| 0.004 | 0.403 | 0.129 | Endothelin receptor antagonist | 0.129 0.004 DBMET01651 | DBMET01651 | |
| 0.008 | 0.416 | 0.059 | Cyclin-dependent kinase 6 inhibitor | 0.059 0.042 DBMET01652 | DBMET01652 | |
| 0.001 | 0.412 | 0.013 | Immunosuppressant Cyclosporine-like | 0.013 0.006 DBMET01651 | DBMET01651 | |
| 0.003 | 0.415 | 0.04 | Nicotinic alpha3beta4 receptor agonist | 0.04 0.01 DBMET01652 | DBMET01652 | |
| 0.008 | 0.424 | 0.077 | Alpha 2 adrenoreceptor agonist | 0.077 0.026 DBMET01652 | DBMET01652 | |
| 0.082 | 0.499 | 0.309 | Caspase 3 stimulant | 0.309 0.074 DBMET01651 | DBMET01651 | |
| 0.008 | 0.438 | 0.053 | 5 Hydroxytryptamine 2B agonist | 0.053 0.011 DBMET01652 | DBMET01652 | |
| 0.069 | 0.499 | 0.171 | RNA-directed DNA polymerase inhibitor | 0.171 0.151 DBMET01652 | DBMET01652 | |
| 0.003 | 0.437 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET01652 | DBMET01652 | |
| 0.112 | 0.548 | 0.383 | Calcium channel L-type activator | 0.383 0.093 DBMET01652 | DBMET01652 | |
| 0.002 | 0.438 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.014 DBMET01652 | DBMET01652 | |
| 0.061 | 0.498 | 0.164 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.164 0.119 DBMET01652 | DBMET01652 | |
| 0.002 | 0.44 | 0.021 | Cyclin T1 inhibitor | 0.021 0.01 DBMET01652 | DBMET01652 | |
| 0.011 | 0.459 | 0.069 | Protein kinase C beta inhibitor | 0.069 0.05 DBMET01652 | DBMET01652 | |
| 0.023 | 0.483 | 0.111 | Cyclooxygenase inhibitor | 0.111 0.11 DBMET01651 | DBMET01651 | |
| 0.114 | 0.576 | 0.231 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.231 0.095 DBMET01652 | DBMET01652 | |
| 0.032 | 0.496 | 0.113 | Peroxidase inhibitor | 0.113 0.108 DBMET01652 | DBMET01652 | |
| 0.038 | 0.504 | 0.128 | Hexokinase inhibitor | 0.128 0.107 DBMET01651 | DBMET01651 | |
| 0.011 | 0.492 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.041 DBMET01652 | DBMET01652 | |
| 0.081 | 0.563 | 0.209 | Nitric-oxide synthase stimulant | 0.209 0.075 DBMET01652 | DBMET01652 | |
| 0.013 | 0.496 | 0.075 | Cathepsin B inhibitor | 0.075 0.026 DBMET01651 | DBMET01651 | |
| 0.02 | 0.508 | 0.156 | Pyruvate kinase inhibitor | 0.156 0.11 DBMET01651 | DBMET01651 | |
| 0.032 | 0.521 | 0.139 | Hemostatic | 0.139 0.082 DBMET01652 | DBMET01652 | |
| 0.056 | 0.547 | 0.161 | MAP kinase kinase 4 inhibitor | 0.161 0.044 DBMET01652 | DBMET01652 | |
| 0.009 | 0.502 | 0.076 | Inducible nitric-oxide synthase inhibitor | 0.076 0.069 DBMET01652 | DBMET01652 | |
| 0.038 | 0.536 | 0.177 | 3C-like protease (Human coronavirus) inhibitor | 0.177 0.067 DBMET01651 | DBMET01651 | |
| 0.035 | 0.547 | 0.362 | Calpain 2 inhibitor | 0.362 0.081 DBMET01651 | DBMET01651 | |
| 0.015 | 0.53 | 0.093 | Protein kinase C gamma inhibitor | 0.093 0.091 DBMET01652 | DBMET01652 | |
| 0.01 | 0.533 | 0.062 | Lysine-specific demethylase 1A inhibitor | 0.062 0.025 DBMET01652 | DBMET01652 | |
| 0.045 | 0.567 | 0.218 | Factor V inhibitor | 0.218 0.004 DBMET01651 | DBMET01651 | |
| 0.01 | 0.534 | 0.061 | Myc inhibitor | 0.061 0.028 DBMET01652 | DBMET01652 | |
| 0.016 | 0.541 | 0.124 | Interleukin 1 beta converting enzyme inhibitor | 0.124 0.032 DBMET01651 | DBMET01651 | |
| 0.007 | 0.533 | 0.047 | Integrin alpha2 antagonist | 0.047 0.014 DBMET01652 | DBMET01652 | |
| 0.012 | 0.545 | 0.083 | MAP kinase kinase 1 inhibitor | 0.083 0.082 DBMET01652 | DBMET01652 | |
| 0.026 | 0.575 | 0.191 | NADPH oxidase inhibitor | 0.191 0.037 DBMET01651 | DBMET01651 | |
| 0.021 | 0.622 | 0.136 | Thiol protease inhibitor | 0.136 0.086 DBMET01651 | DBMET01651 | |
| 0.005 | 0.627 | 0.156 | Check point kinase 2 inhibitor | 0.156 0.029 DBMET01652 | DBMET01652 | |
| 0.039 | 0.668 | 0.185 | Insulysin inhibitor | 0.185 0.182 DBMET01652 | DBMET01652 | |
| 0.019 | 0.674 | 0.061 | Caspase 9 inhibitor | 0.061 0.045 DBMET01651 | DBMET01651 | |
| 0.003 | 0.729 | 0.108 | 5 Hydroxytryptamine 2C agonist | 0.108 0.007 DBMET01652 | DBMET01652 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |